No evidence for a role of the serotonin 4 receptor in five-factor personality traits: A positron emission tomography brain study.

Serotonin (5-HT) brain architecture appears to be implicated in normal personality traits as supported by genetic associations and studies using molecular brain imaging. However, so far, no studies have addressed potential contributions to variation in normal personality traits from in vivo serotoni...

Full description

Bibliographic Details
Published in:	PLoS ONE
Main Authors:	Dea Siggaard Stenbæk, Vibeke Høyrup Dam, Patrick MacDonald Fisher, Nanna Hansen, Liv Vadskjær Hjordt, Vibe Gedsoe Frokjaer
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0184403&type=printable

Similar Items

Serotonin 4 receptor brain binding and oxytocin-promoted affective and social cognition in healthy women – A randomized controlled trial
by: Vibeke Høyrup Dam, et al.
Published: (2024-02-01)

Trait aggression is associated with five‐factor personality traits in males
by: Vibeke H. Dam, et al.
Published: (2021-07-01)

Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study
by: Vibeke Høyrup Dam, et al.
Published: (2022-11-01)

Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
by: Kristin Köhler-Forsberg, et al.
Published: (2020-07-01)

Genetic contributions to brain serotonin transporter levels in healthy adults
by: Silvia Elisabetta Portis Bruzzone, et al.
Published: (2023-09-01)

Sexual health and serotonin 4 receptor brain binding in unmedicated patients with depression—a NeuroPharm study
by: Annika Læbo Rasmussen, et al.
Published: (2023-07-01)

Serotonin transporter gene (SLC6A4) variation and sensory processing sensitivity—Comparison with other anxiety‐related temperamental dimensions
by: Cecilie L. Licht, et al.
Published: (2020-08-01)

Editorial: The psychotherapeutic framing of psychedelic drug administration
by: Maria Beckman, et al.
Published: (2023-01-01)

Association between brain serotonin 4 receptor binding and reactivity to emotional faces in depressed and healthy individuals
by: Anjali Sankar, et al.
Published: (2023-05-01)

Short-term oestrogen as a strategy to prevent postpartum depression in high-risk women: protocol for the double-blind, randomised, placebo-controlled MAMA clinical trial
by: Elisabeth Binder, et al.
Published: (2021-12-01)

Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals
by: Anna Søndergaard, et al.
Published: (2022-10-01)

Is serotonin transporter brain binding associated with the cortisol awakening response? An independent non-replication
by: Juliane Conradi, et al.
Published: (2023-01-01)

Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)
by: Claus Thorn Ekstrøm, et al.
Published: (2022-10-01)

Functional and molecular neuroimaging of menopause and hormone replacement therapy
by: Erika eComasco, et al.
Published: (2014-12-01)

Psychometric Properties of the Verbal Affective Memory Test-26 and Evaluation of Affective Biases in Major Depressive Disorder
by: Liv V. Hjordt, et al.
Published: (2020-06-01)

No association between peripheral serotonin-gene-related DNA methylation and brain serotonin neurotransmission in the healthy and depressed state
by: S. E. P. Bruzzone, et al.
Published: (2024-05-01)

Associations of serotonin-related brain morphology in early adolescence with behavioral and emotional problems
by: Dogukan Koc, et al.
Published: (2025-01-01)

Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study
by: Kristin Köhler-Forsberg, et al.
Published: (2022-07-01)

Functional brain responses to emotional faces after three to five weeks of intake of escitalopram in healthy individuals: a double-blind, placebo-controlled randomised study
by: Sophia Armand, et al.
Published: (2024-02-01)

Cognitive impairment and psychopathology in out-of-hospital cardiac arrest survivors in Denmark: The REVIVAL cohort study protocol
by: Jacob Eifer Moller, et al.
Published: (2020-09-01)

Generalizability of treatment outcome prediction in major depressive disorder using structural MRI: A NeuroPharm study
by: Vincent Beliveau, et al.
Published: (2022-01-01)

Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol
by: Olga B. Baltzersen, et al.
Published: (2020-04-01)

A grassroots approach to peer support by the Danish Reproducibility Network
by: Marta Topor, et al.
Published: (2024-09-01)

Association of neurocognitive function with psychiatric hospitalization and socio-demographic conditions in individuals with bipolar and major depressive disordersResearch in context
by: Anjali Sankar, et al.
Published: (2023-04-01)

Deep phenotyping towards precision psychiatry of first-episode depression — the Brain Drugs-Depression cohort
by: Kristian Høj Reveles Jensen, et al.
Published: (2023-03-01)

Muon to Positron Conversion
by: MyeongJae Lee, et al.
Published: (2022-04-01)

Early cognitive and psychological symptoms in cardiac arrest survivors and mental health outcomes among relatives: findings from the REVIVAL cohort
by: Camilla Dichman, et al.
Published: (2025-07-01)

Analysis of annihilation positron and electron and additional opportunities of the positron-emission tomography
by: A.N. Volobuev, et al.
Published: (2014-04-01)

Five Pitfalls and Solutions of Performance Management in a Selected South African University During Covid-19
by: Kanyangale MacDonald Isaac, et al.
Published: (2022-10-01)

Radiochemistry for positron emission tomography
by: Jian Rong, et al.
Published: (2023-06-01)

Detectors in positron emission tomography
by: Artem Zatcepin, et al.
Published: (2023-02-01)

Sex Differences of Brain Serotonin Synthesis in Patients with Irritable Bowel Syndrome Using α-[11C]methyl-L-tryptophan, Positron Emission Tomography and Statistical Parametric Mapping
by: Akio Nakai, et al.
Published: (2003-01-01)

Relationships between Serotonin Transporter Binding in the Raphe Nuclei, Basal Ganglia, and Hippocampus with Clinical Symptoms in Cervical Dystonia: A [11C]DASB Positron Emission Tomography Study
by: Marenka Smit, et al.
Published: (2018-02-01)

Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer
by: Jorge Daniel Oldan, et al.
Published: (2018-10-01)

Statin Therapy and Vascular Inflammation Detected by Positron Emission Tomography/Computed Tomography in Patients with Psoriasis
by: Hannah Kaiser, et al.
Published: (2021-02-01)

A comparison of five different drug-drug interaction checkers for selective serotonin reuptake inhibitors
by: Shanshan Xu, et al.
Published: (2025-09-01)

Positron Emission Tomography Imaging in Sarcoidosis
by: Beth Vettiyil, et al.
Published: (2013-07-01)

POSITRON EMISSION TOMOGRAPHY IN GYNECOLOGIC ONCOLOGY
by: D. V. Ryzhkova, et al.
Published: (2016-02-01)

Positron emission tomography tracers for synucleinopathies
by: Jie Xiang, et al.
Published: (2025-01-01)

Positron Emission Tomography Scanning and Gastroenterology
by: Jean-Luc Urbain, et al.
Published: (2008-01-01)